Pancreatic cancer
Would you like to receive a message when there is new research on pancreatic cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was investigated — and you receive a notification as soon as new research about Pancreatic cancer is available. View what Premium costs.
Publications and studies (2846)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Integrative single-cell and spatial transcriptomic approaches to decipher the tumor microenvironment and therapeutic resistance in pancreatic cancer. (2026/12/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Stress-specific 14-3-3-client modules in digestive cancers: an evidence-graded review of adaptive survival and therapy resistance. (2026/12/31) ♡
- Methionine restriction plus vitamin B12 antagonism overcomes methionine independence for cancer therapy. (2026/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The forgotten burden: nutrition impact symptoms in colorectal cancer survivorship. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of Serous Cystadenoma. (2026/09/01) ♡
- Oridonin and ponicidin induce GSDME-mediated pyroptosis in pancreatic ductal adenocarcinoma. (2026/09/01) ♡
- Jianpi Huayu decoction alleviates hepatic fibrosis involving coordinated modulation of PPARα-mediated lipid metabolic reprogramming and the ROCK pathway. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting. (2026/08/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Multiple endocrine neoplasia presenting initially as acute pulmonary thromboembolism: a case report]. (2026/08/12) ♡
- Fostering human dignity during chemotherapy: An explorative study on Dignity Therapy in advanced gastric and pancreatic cancer. (2026/08/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neoantigen cancer vaccines in the mRNA Era: antigen selection, platform engineering, and clinical translation. (2026/08/10) ♡
- A ternary association of KRas, EphA2 and integrins controls PDAC cell behaviour. (2026/08/10) ♡
- Oral nano-delivery of a gut microbial metabolite enhances T cell stemness for cancer immunotherapy. (2026/08/10) ♡
- ASO Visual Abstract: Association of Cancer Center Designation with Multimodality Treatment, Perioperative Outcomes, and Survival Among Older Adults with Pancreatic Ductal Adenocarcinoma. (2026/08/10) ♡
- MLH1 promoter methylation in pancreatic ductal adenocarcinoma: frequent but not prognostic. (2026/08/10) ♡
- Stress granules confer an early vulnerability in KRAS-driven pancreatic tumorigenesis. (2026/08/10) ♡
- Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular Analyses. (2026/08/10) ♡
- Chemopreventive Effect of Bitter Melon (Momordica charantia) Juice on Pancreatic Carcinogenesis in LSL-Kras(G12D) (/+); p48(Cre/+) Mice. (2026/08/10) ♡
- Toxoplasma gondii GRA16 enhances the inhibitory effects of standard DNA-damaging chemotherapeutics in liver, pancreatic, and colorectal cancer cells. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Patient-Reported Outcome Measures Following Pancreatectomy for Pancreatic Cancer: A Scoping Review. (2026/08/10) ♡
- Ferroptosis Suppression by the M(6)A Reader IGF2BP1 Underlies Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Imaging and management of biliary complications after biliary interventions. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic cell death: ferroptosis, cuproptosis, and disulfidptosis as a unified framework for targeting metabolic vulnerabilities in disease. (2026/08/10) ♡
- Sex differences in chemotherapy-induced alopecia distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From KRAS inhibition to tumor adaptation: mechanistic layers of resistance and therapeutic strategies. (2026/08/09) ♡
- SMARCB1/INI1-deficient Undifferentiated Carcinoma Presenting as Cancer of Unknown Primary with Massive Hepatic Involvement: Transient Response to FOLFOX plus Nivolumab. (2026/08/08) ♡
- Current Role of Endoscopic Ultrasonography in the Early Detection of Pancreatic Cancer: Recognition of Indirect Imaging Findings and Diagnostic Strategy. (2026/08/08) ♡
- GALNT6-glycosylated LRG1 mediates the interaction between M2 macrophages and pancreatic cancer cells by activating CCR1/PI3K/AKT axis. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in stimuli-responsive hydrogels for liver disease therapy: mechanisms, applications, and translational perspectives. (2026/08/08) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. AAV-delivered miRNA-gated Cre circuits enable programmable gene activation in AFP-active liver tumor models. (2026/08/08) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The KRAS targeting revolution in metastatic pancreatic cancer: insights from the landmark RASolute-302 trial and emerging allele-specific strategies at ASCO 2026. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Post-translational modifications in metabolic reprogramming: implications for metabolic therapy and immunotherapy in cancer. (2026/08/07) ♡
- Redefining biologically borderline resectable pancreatic cancer: a data-driven reassessment of CA19-9 cutoff and a preoperative lymph node metastasis prediction model. (2026/08/07) ♡
- Prior cholecystectomy may identify a biologically aggressive subset of RAS-mutated proximal colon cancer: A 13-year retrospective cohort study. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pain response after palliative-intent radiotherapy for pancreatic cancer: a systematic review. (2026/08/07) ♡
- A Transgenic mouse tolerant to syngeneic cancer cells expressing truncated human epidermal growth factor receptor. (2026/08/07) ♡
- Daraxonrasib in pancreatic cancer: When progress disrupts practice. (2026/08/07) ♡
- Alloimperatorin enhances chemosensitivity by modulating the c-MYC/NBS1 axis to induce sustained DNA damage. (2026/08/07) ♡
- IGF2BP3-mediated regulation of the RNA isoform and modification landscape in pancreatic cancer. (2026/08/07) ♡
- Metabolic reprogramming drives pancreatic β cell neogenesis from α cells. (2026/08/07) ♡
- 3-amino-1,2,4-triazine scaffolds as next-generation PDK inhibitors: Design, mechanistic insights, and efficacy in pancreatic ductal adenocarcinoma. (2026/08/06) ♡
- Type I Collagen Increases Survivin Expression in Pancreatic Cancer Cells. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Daraxonrasib and Beyond: Pan-RAS Inhibition, Resistance, and Next-Generation Strategies. (2026/08/06) ♡
- Endoscopic Ultrasound-Guided Fine Needle Aspiration Diagnosis of Pancreatic Intraductal Tubulopapillary Neoplasm: A Cytology Case Report. (2026/08/06) ♡
- Prevalence and Imaging Characteristics of Chronic Calcific Pancreatitis in Patients With Newly Diagnosed Pancreatic Ductal Adenocarcinoma. (2026/08/06) ♡
- Redox-responsive polymeric nanocarriers for targeted delivery of bruceantin to pancreatic cancer. (2026/08/06) ♡
- Rethinking imaging-based IPMN subtype classification: is mixed-type a necessary radiologic category? (2026/08/06) ♡
- Association of Cancer Center Designation with Multimodality Treatment, Perioperative Outcomes, and Survival among Older Adults with Pancreatic Ductal Adenocarcinoma. (2026/08/06) ♡
- ASO Visual Abstract: Hepatectomy After Progressive Disease Following Chemotherapy for Colorectal Liver Metastases: A Japanese Nationwide Cohort Study. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Intersection of Immunosenescence, Cellular Senescence, and Type 1 Diabetes: Paving the Way for Future Interventions. (2026/08/06) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.